SEC Tracker
Get the app

Anaptysbio ANAB

AnaptysBio reports stock transaction

Hollings Renton, insider filing for ANAB

Form
4
Filed
Importance
Routine
  1. Oct 1, 2026 - 5,000 shares acquired
  2. Oct 1, 2026 - 5,000 shares sold
  3. Stock price range $49.435 - $50.37

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Anaptysbio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Amphastar Pharmaceuticals AMPH public float $633M, Jun 30, 2025
  2. Stoke Therapeutics STOK public float $592M, Jun 30, 2025
  3. Trevi Therapeutics TRVI public float $588M, Jun 30, 2025
  4. ImmunityBio IBRX public float $690M, Jun 30, 2025
  5. Anavex Life Sciences AVXL public float $708M, Mar 31, 2025, over 18 months old

Data on this page was fetched . The filing on SEC.gov is the record.